Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Doxepin Hydrochloride Capsules USP, 150mg, a generic version of Sinequan Capsules, 150mg. Edenbridge will begin shipping this newly approved product shortly. For more information please contact the Company directly at info@dexcelpharmausa.com.
Doxepin Hydrochloride Capsules, USP Approval
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.